BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 700 shares, a growth of ∞ from the April 30th total of 0 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 3,027 shares, the short-interest ratio is currently 0.2 days.
BioForce Nanosciences Price Performance
Shares of BFNH stock opened at $0.85 on Tuesday. The stock’s 50-day simple moving average is $0.63 and its 200-day simple moving average is $0.58. BioForce Nanosciences has a fifty-two week low of $0.18 and a fifty-two week high of $1.02.
About BioForce Nanosciences
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
Read More
- Five stocks we like better than BioForce Nanosciences
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
